Merck flies to Trenton the same week as a key FDA advisory committee meeting

Merck flew from Westfield-Barnes Regional Airport in Massachusetts to Trenton Mercer Airport in New Jersey on June 2, a 41-minute hop in the company's Gulfstream G650ER, tail N822MK. The flight arrived just before midnight, putting the company's leadership within easy reach of its Rahway headquarters.

The same week, the FDA's Oncologic Drugs Advisory Committee is scheduled to meet on June 4 to discuss Merck's supplemental Biologics License Application for Keytruda in combination with chemotherapy for certain gastric cancers, per the FDA's public calendar. The meeting could shape the drug's label expansion, a key growth driver for the company's oncology portfolio.

Merck maintains a two-aircraft fleet based near its New Jersey headquarters, and the short flight from Massachusetts likely reflects a business trip or a return from a meeting in the Boston biotech corridor. The timing aligns with a regulatory milestone that could affect the company's near-term outlook.